These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 12219149)

  • 21. Challenges in operationalizing the DSM-IV clinical significance criterion.
    Beals J; Novins DK; Spicer P; Orton HD; Mitchell CM; Barón AE; Manson SM; Big Crow CK; Buchwald D; Chambers B; Christensen ML; Dillard DA; DuBray K; Espinoza PA; Flemming CM; Frederick AW; Gurley D; Jervis LL; Jim SM; Kaufman CE; Keane EM; Klein SA; Lee D; McNutly MC; Middlebrook DL; Moore LA; Nez TD; Norton IM; Randall CJ; Sam A; Shore JH; Simpson SG; Yazzie LL;
    Arch Gen Psychiatry; 2004 Dec; 61(12):1197-207. PubMed ID: 15583111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and validation of a comprehensive fecal incontinence questionnaire.
    Macmillan AK; Merrie AE; Marshall RJ; Parry BR
    Dis Colon Rectum; 2008 Oct; 51(10):1502-22. PubMed ID: 18626716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis.
    Thombs BD; Hudson M; Schieir O; Taillefer SS; Baron M;
    Arthritis Rheum; 2008 Mar; 59(3):438-43. PubMed ID: 18311754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The global burden of youth diabetes: perspectives and potential.
    Aanstoot HJ; Anderson BJ; Daneman D; Danne T; Donaghue K; Kaufman F; Réa RR; Uchigata Y
    Pediatr Diabetes; 2007 Oct; 8 Suppl 8():1-44. PubMed ID: 17767619
    [No Abstract]   [Full Text] [Related]  

  • 25. Financial consequences from smoking-related diseases in middle-income countries: Evidence and lessons from Mexico.
    Arredondo A; Recaman AL; Pinzon C; Azar A
    Int J Health Plann Manage; 2018 Apr; 33(2):e454-e463. PubMed ID: 29363795
    [No Abstract]   [Full Text] [Related]  

  • 26. Heart health has an adverse future forecast in New Zealand: an alarm call to action across the continuum.
    Sharpe N
    N Z Med J; 2006 Apr; 119(1232):U1936. PubMed ID: 16633395
    [No Abstract]   [Full Text] [Related]  

  • 27. Approaches to the evaluation of outbreak detection methods.
    Watkins RE; Eagleson S; Hall RG; Dailey L; Plant AJ
    BMC Public Health; 2006 Oct; 6():263. PubMed ID: 17059615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reliability and validity of a Chinese version of the Impact of Pediatric Epilepsy Scale.
    Lv RJ; Wu LW; Jin LR; Lu Q; Wang MY; Liu H
    Epilepsy Behav; 2009 Sep; 16(1):150-5. PubMed ID: 19679516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Periodontal infections and cardiovascular disease: is it a mere association?
    Humagain M; Nayak DG; Uppoor AS
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):379-82. PubMed ID: 18603938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating the cost of epilepsy in Europe: a review with economic modeling.
    Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
    Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost-effectiveness of policies for the safe and appropriate use of injection in healthcare settings.
    Dziekan G; Chisholm D; Johns B; Rovira J; Hutin YJ
    Bull World Health Organ; 2003; 81(4):277-85. PubMed ID: 12764494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construct validity of the endoscopic sinus surgery simulator: II. Assessment of discriminant validity and expert benchmarking.
    Fried MP; Sadoughi B; Weghorst SJ; Zeltsan M; Cuellar H; Uribe JI; Sasaki CT; Ross DA; Jacobs JB; Lebowitz RA; Satava RM
    Arch Otolaryngol Head Neck Surg; 2007 Apr; 133(4):350-7. PubMed ID: 17438249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validity of the revised Impact on Family (IOF) scale.
    Williams AR; Piamjariyakul U; Williams PD; Bruggeman SK; Cabanela RL
    J Pediatr; 2006 Aug; 149(2):257-61. PubMed ID: 16887446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the Multiple Sclerosis International Quality of Life questionnaire.
    Simeoni M; Auquier P; Fernandez O; Flachenecker P; Stecchi S; Constantinescu C; Idiman E; Boyko A; Beiske A; Vollmer T; Triantafyllou N; O'Connor P; Barak Y; Biermann L; Cristiano E; Atweh S; Patrick D; Robitail S; Ammoury N; Beresniak A; Pelletier J;
    Mult Scler; 2008 Mar; 14(2):219-30. PubMed ID: 17942521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Asthma and cost of illness].
    Beyhun NE; Cilingiroğlu N
    Tuberk Toraks; 2004; 52(4):386-92. PubMed ID: 15558364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global incidence study.
    Donnan GA
    Int J Stroke; 2014 Jan; 9(1):1. PubMed ID: 24350868
    [No Abstract]   [Full Text] [Related]  

  • 37. Of P-values and Bayes: a modest proposal.
    Goodman SN
    Epidemiology; 2001 May; 12(3):295-7. PubMed ID: 11337600
    [No Abstract]   [Full Text] [Related]  

  • 38. It's time to rehabilitate the P-value.
    Weinberg CR
    Epidemiology; 2001 May; 12(3):288-90. PubMed ID: 11337598
    [No Abstract]   [Full Text] [Related]  

  • 39. THE ELECTROCARDIOGRAM IN EPIDEMIOLOGICAL STUDIES: REPRODUCIBILITY, VALIDITY, AND INTERNATIONAL COMPARISON.
    HIGGINS IT; KANNEL WB; DAWBER TR
    Br J Prev Soc Med; 1965 Apr; 19(2):53-68. PubMed ID: 14319212
    [No Abstract]   [Full Text] [Related]  

  • 40. Low P-values or narrow confidence intervals: which are more durable?
    Poole C
    Epidemiology; 2001 May; 12(3):291-4. PubMed ID: 11337599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.